RankAlpha logo
Back to Rankings

ALT

AltimmuneF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
ALT vs peer average
28/100
ALT vs. peer average (F vs. D)
Grade spread
A 1 · C 2 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

PRME is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $565.33M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPRMEPrime Medicine
ALT
Altimmune
PRME
Prime Medicine
Grade
F
D
Momentum
15
55
Value
41
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs PRME

ALT / PRME
Grade Position
Below peers
ALT vs. peer average (F vs. D)
28/100
Momentum
15
PRME
Value
41
ALT
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ALT
1
PRME
Prime Medicine Inc Common
D
40/100
-1
2
RLMD
Relmada Therapeutics Inc Common
C
60/100
-2
3
FDMT
4D Molecular Therapeutics Inc Common
F
20/100
Even
4
MLAB
Mesa Laboratories Inc Common
D
40/100
-1
5
MYGN
Myriad Genetics Inc Common
A
100/100
-4
PRME is the first peer returned for this comparison set.